Skip to main content
Log in

Simultaneous treatment with carbimazole and granulocyte-colony stimulating factor in a patient with thyrotoxicosis and carbimazole induced neutropenia

  • Case Report
  • Published:
Central European Journal of Medicine

Abstract

We describe a patient who was admitted with uncontrolled thyrotoxicosis and carbimazole induced neutropenia. She required 80 mg of carbimazole daily. The patient declined radio-iodine treatment because she had a little child and wished to have thyroid surgery. She received four doses of filgrastim (Granulocyte-colony stimulating factor) which maintained the neutrophil count within a reasonable level while she continued to receive carbimazole to prepare her for surgery. After a curative subtotal thyroidectomy and discontinuation of the carbimazole, the patient’s white cell count remained normal. Subsequently the patient was euthyroid on levothyroxine replacement. Carbimazole should always be discontinued if neutropenia occurs but this case demonstrates that in exceptional circumstances filgrastim can be an effective therapy while continuing carbimazole in the short term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. Biswas, A. You-hern, J.M. Goldman and J.M. Schwartz: “Case report: aplastic anemia associated with antithyroid drugs”, Am. J. Med. Sci., Vol. 301, (1991), pp. 190–194

    Article  PubMed  CAS  Google Scholar 

  2. G. Birchell and T. Cheetham: “Juvenile thyrotoxicosis; can we do better?”, Arch. Dis. Child., Vol. 89(8), (2004), pp. 745–750

    Google Scholar 

  3. U. Srinivas, S. Stanaway, R. Worth and D. Ewins: “Delayed carbimazole induced agranulocytosis precipitating thyroid crisis”, Endocrine abstracts, Vol. 5, (2003), P27.

    Google Scholar 

  4. F. Joseph, N. Younis and D. Bowen Jones: “Treatment of carbimazole-induced agranulocytosis and sepsis with granulocyte colony stimulating factor”, Int. J. Clin. Prac., Vol. 57(2), (2003), pp.145–146

    Google Scholar 

  5. G. Wilcox, R. Wong, P.J. Elliott, D.J. Topliss and J.R. Sockigt: “Recovery from Carbimazole-Induced Aplastic Anaemia”, Int. J. Endocrinol. Metab., Vol. 1, (2003), pp. 41–43

    Google Scholar 

  6. D. Usha, D.M. Thatte and S.A. Dahanukar: “Therapeutic potential of the haematopoietic growth factors”, J. Postgrad. Med., Vol. 40(4), (1994), pp. 210–15

    Google Scholar 

  7. A. Oyama, K. Ota, S. Asano, F. Takaku, T. Miyazaki, Y. Uzuka, M. Omine, S. Furusawa, K. Hirashima, K. Sanpi et al: “Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for Non Hodgkin’s lymphoma”, Nippon Gan. Chiryo. Gakkai. Shi., Vol. 25(8), (1990), pp. 1619–1634.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Talapatra, I., Nagareddy, V.R., Bhavnani, M. et al. Simultaneous treatment with carbimazole and granulocyte-colony stimulating factor in a patient with thyrotoxicosis and carbimazole induced neutropenia. cent.eur.j.med 1, 419–423 (2006). https://doi.org/10.2478/s11536-006-0036-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-006-0036-5

Keywords

Navigation